Together with Abacus, Gronkowski will launch a complementary health and wellness line of CBD products in early 2020. These CBD products will be developed with Gronkowski's first-hand insights on pain management and recovery combined with Abacus's 15 years of pharmaceutical experience specializing in natural solutions. The new Gronk-inspired products will continue to meet the high quality standards of Abacus—using U.S. sourced broad-spectrum, CBD-rich hemp oil that does not contain THC, and therefore, is not psychoactive.